Skip to content
HowShorted

BIORA THERAPEUTICS, INC. short interest in 2023

In 2023, BIORA THERAPEUTICS, INC.'s disclosed short interest ran from 3.57% of shares outstanding on 31 Mar 2023 to 1.89% on 29 Dec 2023, a change of -1.68 percentage points. The year's high was 3.66% on 31 Oct 2023 and its low 1.24% on 30 Nov 2023, averaging 2.76% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.22 days on 14 Apr 2023. Full history: BIORA THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for BIORA THERAPEUTICS, INC. in 2023

2023 in figures

Start of year
3.57% (31 Mar 2023)
End of year
1.89% (29 Dec 2023)
Change
-1.68 pp
High
3.66% (31 Oct 2023)
Low
1.24% (30 Nov 2023)
Average
2.76%
Highest days to cover
7.22 (14 Apr 2023)
SEC filings marked
8

Every report in 2023

BIORA THERAPEUTICS, INC. short interest in 2023
SettlementShort interestDays to coverFilings since previous
31 Mar 20233.57%3.1010-K filed, results (8-K)
14 Apr 20233.57%7.22
28 Apr 20233.58%6.98
15 May 20233.30%2.9010-Q filed, results (8-K)
31 May 20233.48%1.15
15 Jun 20233.47%1.19
30 Jun 20233.13%3.20
14 Jul 20232.31%3.64
31 Jul 20232.01%3.32
15 Aug 20231.46%3.6110-Q filed, results (8-K)
31 Aug 20231.33%3.37
15 Sep 20232.25%2.70
29 Sep 20233.12%2.69
13 Oct 20233.41%5.54
31 Oct 20233.66%2.43
15 Nov 20232.76%2.9210-Q filed, results (8-K)
30 Nov 20231.24%1.00
15 Dec 20232.85%1.00
29 Dec 20231.89%1.00

See also: BIORA THERAPEUTICS, INC.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.